Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
2 studies found for:    18580611 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Not yet recruiting Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy
Condition: HIV
Intervention: Biological: HXTC infusion
2 Completed Immunogenicity and Safety of 2 Schedules of ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients
Condition: HIV Infection
Interventions: Biological: one injection of vCP1452 at W0, W4, W8 and W20;   Biological: one injection of vCP1452 at W4, W8 and W20;   Biological: one injection of placebo at W0, W4, W8, W20 or at W4, W8,W20
To Top

† Indicates status has not been verified in more than two years